Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,466.6
-5.0 (-0.20%)

 

  • STI Straits Times Index
    2,466.6
    -5.0 (-0.20%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,504.8
    0.9 (0.06%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    23,459.0
    183.5 (0.79%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,218.1
    -6.3 (-0.20%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    23,185.1
    -354.0 (-1.50%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    4,870.0
    -9.1 (-0.19%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,275.6M
  • Value: 1,346.5M
  • Rise: 149
  • Fall: 147
  • Unch: 483

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Sembcorp Marine0.146+0.002
HPH Trust USD0.164+0.018
Beverly JCG0.001-0.001
Jiutian Chemical0.048-0.002
Singtel2.120+0.020
CapitaMall Trust1.930-0.060
ThaiBev0.605+0.010
Keppel Corp4.450+0.150
Golden Agri-Res0.142+0.001
Rex Intl0.141-0.001

World Indices

World Indices
Name Last Change
Nasdaq 10,672.3 +39.3
HSI 23,235.4 -75.7
HSCEI 9,302.6 -68.6
Jakarta 4,945.8 +103.0
Nikkei 225 23,204.6 +116.8
SSE Comp 3,219.4 -3.8
Shanghai A 3,374.1 -4.0
Shanghai B 247.4 +0.8
KOSPI 2,278.8 +6.1

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

MATINAS BIOPHARMA HOLDINGS INC MATINAS BIOPHARMA HOLDINGS INC
Updated on 29 Sep 2020 (End of trading day)
Last (USD): 0.770 Change: -0.003 High: 0.794 Remarks: -
Change (%): -0.34 Low: 0.764
Open 0.783 Yesterday's Close 0.7726000000000001
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 1,335,480 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -0.19894 Trailing EPS (USD) e -0.23244 NAV (USD) b 0.7487
PE a - Trailing PE f - Price / NAV b 1.0284
Dividend (USD) d - Cash In Hand (USD) g 0.1642 Issued & Paid-up Shares c 198,873,000
Dividend Yield (%) d - Price / Cash In Hand g 4.689 Treasury Shares h -
Market Cap (M) 70.818 Enterprise Value (M) 10.615
Piotroski F Score 1 Exchange Code MTNB Par Value ( $ ) n.a.
52 Weeks Volatility (%) 105.39 Free Float (%) 86.4
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 08 Jul 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 02 Mar 2017.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference MATINAS BIOPHARMA HOLDINGS INC NYSE American 70.818 - - 1.0284 -
Industry Biotechnology NYSE American 100.945 - - 3.4534 -
Local Peer PFENEX INC NYSE American 300.230 283.745 - 4.0630 -
Local Peer NANOVIRICIDES INC NYSE American 249.765 - - 17.4449 -
Local Peer IBIO INC NYSE American 193.992 - - 48.9461 -
Local Peer LINEAGE CELL THERAPEUTICS INC NYSE American 141.282 - - 1.4208 -
Local Peer CEL-SCI CORP NYSE American 115.020 - - 6.0490 -
Local Peer AIM IMMUNOTECH INC NYSE American 84.143 - - 1.8191 -
Local Peer PALATIN TECHNOLOGIES INC NYSE American 73.589 - - - -
Local Peer 22ND CENTURY GROUP INC NYSE American 66.794 - - 1.2400 -
Local Peer SYNTHETIC BIOLOGICS INC NYSE American 62.187 - - -8.3893 -
Local Peer ARMATA PHARMACEUTICALS INC NYSE American 55.633 - - 1.8770 -
Local Peer INDIA GLOBALIZATION CAPITAL INC NYSE American 33.323 - - 1.3402 -
Local Peer ORAGENICS INC NYSE American 28.707 - - 17.8165 -
Other Local Peers CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), NOVABAY PHARMACEUTICALS INC (NYSE American)
Global Peer AMGEN INC NASDAQ 145,427.820 18.545 19.924 13.6437 2.359
Global Peer AMGEN-T HKEx 1,083,533.900 17.635 19.045 13.1159 2.480
Global Peer CSL ASX 134,459.174 42.872 42.872 14.1825 0.993
Global Peer GILEAD SCIENCES INC NASDAQ 77,856.012 14.455 - 4.3189 4.098
Global Peer VERTEX PHARMACEUTICAL NASDAQ 70,406.835 59.829 33.837 9.3636 -
Global Peer REGENERON PHARMACEUTICALS INC NASDAQ 61,027.498 28.844 20.455 6.7379 -
Global Peer ILLUMINA INC NASDAQ 44,712.980 44.624 64.521 9.7990 -
Global Peer BIOGEN INC NASDAQ 44,699.676 7.591 7.542 3.9527 -
Global Peer SEATTLE GENETICS INC NASDAQ 33,226.467 - - 18.3159 -
Global Peer WUXI BIO HKEx 253,456.475 220.479 176.023 16.9673 -
Other Global Peers MODERNA INC (NASDAQ), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), ALEXION PHARMACEUTICAL INC (NASDAQ), BEIGENE (HKEx), SINO BIOPHARM (HKEx), IMMUNOMEDICS INC (NASDAQ), INCYTE CORPORATION (NASDAQ), ALNYLAM PHARMACEUTICALS INC (NASDAQ), BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), EXACT SCIENCES CORP (NASDAQ), ZAI LAB-SB (HKEx), BIOMARIN PHARMACEUTICAL (NASDAQ), 10X GENOMICS INC (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), EXELIXIS INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), NOVAVAX INC (NASDAQ), ACCELERON PHARMA (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), EMERGENT BIOSOLUTIONS INC (NYSE), ALLOGENE THERAPEUTICS INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), BRIDGEBIO PHARMA INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), Lonza (SGX), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), FIBROGEN INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), RELAY THERAPEUTICS INC (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), INSMED INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), IMMUNOVANT INC (NASDAQ), GENSCRIPT BIO (HKEx), 3SBIO (HKEx), DECIPHERA PHARMACEUTICALS INC (NASDAQ), ALKERMES PLC (NASDAQ), VAXCYTE INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), MESOBLAST LTD (ASX), AIMMUNE THERAPEUTICS INC (NASDAQ), XENCOR INC (NASDAQ), VIVA BIOTECH (HKEx), INTRA-CELLUAR THERAPIES INC (NASDAQ), HAOHAI BIOTEC (HKEx), EIDOS THERAPEUTICS INC (NASDAQ), MYOVANT SCIENCES LTD (NYSE), BENITEC BIOPHARMA INC (NASDAQ), ALPHAMAB-B (HKEx), EDITAS MEDICINE INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), VERACYTE INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), ALLOVIR INC (NASDAQ), UNIQURE N.V. (NASDAQ), CYTOKINETICS INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), CORTEXYME INC (NASDAQ), VIELA BIO INC (NASDAQ), SUMMIT THERAPEUTICS INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), MACROGENICS INC (NASDAQ), KYMERA THERAPEUTICS INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), COMPUGEN (NASDAQ), COMPASS PATHWAYS PLC UNSPON ADS REP 1 ORD SHS (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), EPIZYME INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC SPON ADS EACH REP 6 ORD SHS (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), PRELUDE THERAPEUTICS INC (NASDAQ), ZENTALIS PHARMACEUTICALS INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), ARCUS BIOSCIENCES INC (NYSE), APPLIED MOLECULAR TRANSPORT INC (NASDAQ), AVIDITY BIOSCIENCES INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), NKARTA INC (NASDAQ), POLYNOVO LIMITED (ASX), ESPERION THERAPEUTICS INC (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), REGENXBIO INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), DYNE THERAPEUTICS INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), FRONTAGE (HKEx), RETROPHIN INC (NASDAQ), ARVINAS INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), ALECTOR INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), ITEOS THERAPEUTICS INC (NASDAQ), TAYSHA GENE THERAPIES INC (NASDAQ), PERSONALIS INC (NASDAQ), MORPHIC HOLDING INC (NASDAQ), AKOUOS INC (NASDAQ), PLIANT THERAPEUTICS INC (NASDAQ), ASCENTAGE-B (HKEx), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), NANTKWEST INC (NASDAQ), VAXART INC (NASDAQ), AGENUS INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), VBI VACCINES INC CDA (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), INHIBRX INC (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), KADMON HLDGS INC (NYSE), IMMUNOGEN INC (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), IMMATICS N V (NASDAQ), PRECIGEN INC (NASDAQ), OMEROS CORP (NASDAQ), PASSAGE BIO INC (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), POSEIDA THERAPETUICS INC (NASDAQ), FORTE BIOSCIENCES INC (NASDAQ), XBIOTECH INC (NASDAQ), FREELINE THERAPEUTICS HLDGS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), DPHARMA (Bursa), ZIOPHARM ONCOLOGY INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), GERON CORP (NASDAQ), HUMANIGEN INC (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), ATHIRA PHARMA INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), RADIUS HEALTH INC (NASDAQ), ATRECA INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), ARDELYX INC (NASDAQ), IVERIC BIO INC (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), AVROBIO INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), SINOMAB BIO-B (HKEx), CYMABAY THERAPEUTICS INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), KINTOR PHARMA-B (HKEx), VIKING THERAPEUTICS INC (NASDAQ), TREVENA INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), INVENTIVA SA SPON ADS EACH REP 1 ORD SHS (NASDAQ), AVID BIOSERVICES INC (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), ATHERSYS INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), PROTHENA CORP PLC (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), ASCLETIS-B (HKEx), RIGEL PHARMACEUTICALS INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), LEE'S PHARM (HKEx), XENON PHARMACEUTICALS INC (NASDAQ), PDL BIOPHARMA INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), KAMADA (NASDAQ), PANDION THERAPEUTICS INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), MERUS B V (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), ESSEX BIO-TECH (HKEx), PRECISION BIOSCIENCES INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), AEGLEA BIOTHERAPEUTICS INC (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), TELIX PHARMACEUTIC (ASX), IMV INC (NASDAQ), ASPIRA WOMENS HEALTH INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), METACRINE INC (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), CHIASMA INC (NASDAQ), AFFIMED N V (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), CABALETTA BIO INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), LARIMAR THERAPEUTICS INC (NASDAQ), NEXTCURE INC (NASDAQ), CHECKMATE PHARMACEUTICALS INC (NASDAQ), MEDICINOVA INC (NASDAQ), VERASTEM INC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), XOMA CORP (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), ADICET BIO INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), ADURO BIOTECH INC (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), MEDICENNA THERAPEUTICS CORP (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), ENOCHIAN BIOSCIENCES INC (NASDAQ), OTONOMY INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), AXCELLA HEALTH INC (NASDAQ), NEXT SCIENCE LTD (ASX), LEXICON PHARMACEUTICALS INC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), CHIMERIX INC (NASDAQ), SESEN BIO INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), IMUGENE LIMITED (ASX), FENNEC PHARMACEUTICALS INC (NASDAQ), CONTRAFECT CORP (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), INMUNE BIO INC (NASDAQ), EQUILLIUM INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), MINERVA NEUROSCIENCES INC (NASDAQ), CELYAD ONCOLOGY ADS EACH REPR 1 ORD (NASDAQ), BELLUS HEALTH INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), LUMOS PHARMA INC (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), INFLARX N V (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), 9 METERS BIOPHARMA INC (NASDAQ), ORGENESIS INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), UNI-BIO GROUP (HKEx), ENZO BIOCHEM INC (NYSE), EVOGENE LTD (NASDAQ), WINDTREE THERAPEUTICS INC (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), NEUREN PHARMACEUTICALS LTD (ASX), ANTEOTECH LIMITED (ASX), AVALON GLOBOCARE CORP (NASDAQ), IMMUTEP LTD (ASX), CYNATA THERAPEUTICS LTD (ASX), OUTLOOK THERAPEUTICS INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), ARAVIVE INC (NASDAQ), BIONOMICS LTD (ASX), DIAMEDICA THERAPEUTICS INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), SYNLOGIC INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), BIOVIE INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), SAVARA INC (NASDAQ), KAZIA THERAPEUTICS LIMITED (ASX), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), CURIS INC (NASDAQ), COHBAR INC (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), INVEX THERAPEUTICS LTD NPV (ASX), MICROBOT MEDICAL INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), SOLIGENIX INC (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), MERRIMACK PHARMACEUTICALS INC (NASDAQ), RECRO PHARMA INC (NASDAQ), MEMPHASYS LTD (ASX), ONCONOVA THERAPEUTICS INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), GENETIC TECHNOLOGIES (ASX), CT ENTERPRISE (HKEx), MIRAGEN THERAPEUTICS INC (NASDAQ), BIOTRON (ASX), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), GREENWICH LIFESCIENCES INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), OCUGEN INC (NASDAQ), PRECIPIO INC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), ALTERITY THERAPEUTICS LIMITED (ASX), ATYR PHARMA INC (NASDAQ), VACCINEX INC (NASDAQ), SONNET BIOTHERAPEUTICS HLDGS INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), REGENEUS LTD (ASX), BELLICUM PHARMACEUTICALS (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), RHINOMED LIMITED (ASX), Suntar Eco-City (SGX), ACHIEVE LIFE SCIENCE INC (NASDAQ), BIOSINO BIO-TEC (HKEx), PRESCIENT THERAPEUTICS LIMITED (ASX), ACORDA THERAPEUTICS INC (NASDAQ), BIOCARDIA INC (NASDAQ), REGENT PACIFIC (HKEx), ARCA BIOPHARMA INC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), ADVAXIS INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), CONSTELLATION TECHNOLOGIES LTD (ASX), APTEVO THERAPEUTICS INC (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), ACTINOGEN MEDICAL LTD (ASX), AIKIDO PHARMA INC (NASDAQ), ADALTA LTD (ASX), ENDRA LIFE SCIENCES INC (NASDAQ), HISTOGEN INC (NASDAQ), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), ADITX THERAPEUTICS INC (NASDAQ), CYCLACEL PHARMACEUTICALS INC (NASDAQ), CONTANGO ASSET MANAGEMENT LIMITED (ASX), BIO-PATH HOLDINGS INC (NASDAQ), PATRYS LIMITED (ASX), AMPLIA THERAPEUTICS LTD (ASX), ITERUM THERAPEUTICS PLC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), HOLISTA COLLTECH LIMITED (ASX), PLUS THERAPEUTICS INC (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), REXAHN PHARMACEUTICALS INC (NASDAQ), ANATARA LIFESCIENCES LTD (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), AUSTRALIAN PRIMARY HEMP LTD (ASX), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), CRYOSITE (ASX), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), LIVING CELL TECHNOLOGIES (ASX), SENESTECH INC (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), NANOLLOSE LTD (ASX), LEAF RESOURCES LTD (ASX), HAO WEN HLDGS (HKEx), FACTOR THERAPEUTICS LIMITED (ASX), AURIS MEDICAL HOLDING LTD (NASDAQ), GEOVAX LABS INC (NASDAQ)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.023
-2.90 %
10 Days --0.008
-1.03 %
20 Days -+0.004
+0.52 %
Medium Term Return 3 Months --0.012
-1.53 %
6 Months -+0.214
+38.49 %
1 Year -+0.138
+21.84 %
Long Term Return 2 Years --0.240
-23.76 %
3 Years --0.560
-42.11 %
Annualised Return Annualised --
-16.65 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.490 - 2.490 Change From 1 Year Low +0.280 % Change From 1 Year Low (%) +57.14
Change From 1 Year High -1.720 % Change From 1 Year High (%) -69.08
2 Years Range 0.490 - 2.490 Change From 2 Years Low +0.280 % Change From 2 Years Low (%) +57.14
Change From 2 Years High -1.720 % Change From 2 Years High (%) -69.08
5 Years Range 0.324 - 3.950 Change From 5 Years Low +0.446 % Change From 5 Years Low (%) +137.87
Change From 5 Years High -3.180 % Change From 5 Years High (%) -80.51
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Matinas BioPharma Holdings, Inc. is a clinical-stage biopharmaceutical company, which focuses on enabling the delivery of life-changing medicines using its LNC platform technology. The company's proprietary, disruptive technology utilizes lipid nano-crystals which can encapsulate small molecule drugs, oligonucleotides, vaccines, peptides, proteins, and other medicines potentially making them safer, more tolerable, less toxic, and orally bioavailable. Its anti-fungal product candidate, MAT2203, delivers broad-spectrum fungicidal agent, amphotericin B, and is being developed to prevent invasive fungal infections in patients with acute lymphoblastic leukemia. The company was founded by Jerome D. Jabbour in May 2013 and is headquartered in Bedminster, NJ.

Historical Price Data

Date Open High Low Close Volume VWAP
29 Sep 2020 0.783 0.794 0.764 0.770 1,335,480 -
28 Sep 2020 0.798 0.800 0.768 0.773 959,148 -
25 Sep 2020 0.770 0.798 0.760 0.791 794,166 -
24 Sep 2020 0.795 0.798 0.742 0.772 1,031,037 -
23 Sep 2020 0.810 0.810 0.782 0.793 1,323,745 -
22 Sep 2020 0.799 0.810 0.772 0.795 1,092,762 -
21 Sep 2020 0.800 0.800 0.770 0.788 1,165,988 -
18 Sep 2020 0.810 0.810 0.780 0.804 1,738,188 -
17 Sep 2020 0.778 0.800 0.755 0.796 1,447,610 -
16 Sep 2020 0.800 0.810 0.759 0.778 1,471,983 -
15 Sep 2020 0.750 0.835 0.730 0.774 3,422,626 -
14 Sep 2020 0.712 0.746 0.693 0.720 1,592,115 -
11 Sep 2020 0.671 0.735 0.670 0.693 1,531,172 -
10 Sep 2020 0.687 0.691 0.661 0.667 1,919,542 -
09 Sep 2020 0.698 0.720 0.685 0.693 2,130,990 -
08 Sep 2020 0.710 0.722 0.684 0.719 1,206,092 -
04 Sep 2020 0.750 0.750 0.681 0.732 3,180,975 -
03 Sep 2020 0.750 0.760 0.737 0.756 1,530,049 -
02 Sep 2020 0.790 0.792 0.735 0.765 2,545,054 -
01 Sep 2020 0.784 0.793 0.767 0.780 1,366,793 -
31 Aug 2020 0.800 0.800 0.776 0.782 1,605,572 -
28 Aug 2020 0.796 0.799 0.771 0.788 1,972,256 -
Summary
Current 2 Weeks
(16 Sep 2020 to 29 Sep 2020)
0.800 0.810 0.742 0.770 12,360,107 -
Previous 2 Weeks
(01 Sep 2020 to 15 Sep 2020)
0.784 0.810 0.742 0.774 20,425,408 -
4 Weeks from
(04 Aug 2020 to 31 Aug 2020)
0.821 0.821 0.742 0.782 65,915,987 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.